Horizon Therapeutics Publ... (HZNP)
NASDAQ: HZNP
· Real-Time Price · USD
116.30
0.00 (0.00%)
At close: Jan 16, 2025, 10:00 PM
Horizon Therapeutics Public Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 127.07M | 54.68M | 120.41M | 135.84M | 60.97M | 204.26M | 173.18M | 326.54M | 158.12M | -123.35M |
Depreciation & Amortization | 96.28M | 94.86M | 98.77M | 99.08M | 97.43M | 95.11M | 96.53M | 94.48M | 91.92M | 70.82M |
Stock-Based Compensation | 60.27M | 58.12M | 44.59M | 45.07M | 45.15M | 47.3M | 48.69M | 54.8M | 54.42M | 61.17M |
Other Working Capital | -20.42M | -13.63M | -33.59M | 9.1M | -37.01M | -85.37M | 7.15M | 82.78M | 27.66M | -203.2M |
Other Non-Cash Items | -6.4M | 1.04M | 41.03M | 14.36M | 65.87M | 4.77M | 31.58M | 3.46M | 47.95M | 7.7M |
Deferred Income Tax | -4.64M | -87.31M | 41.16M | 11.69M | 30.86M | -33.9M | 46.92M | -129.82M | 10.66M | -28.77M |
Change in Working Capital | -111.12M | -35.07M | 80.43M | 60.43M | -51.09M | -101.75M | 141.65M | 61.57M | -273.67M | 8.7M |
Operating Cash Flow | 161.47M | 86.32M | 426.39M | 366.46M | 249.2M | 215.79M | 538.56M | 411.04M | 89.4M | -3.73M |
Capital Expenditures | -18.47M | -39.13M | -47.11M | -29.82M | -10.15M | -39.2M | -19.97M | -73.94M | -13.92M | -18.33M |
Cash Acquisitions | n/a | n/a | 28.45M | n/a | 2.03M | -3.12M | -2M | -67.94M | -67.97M | -2.71B |
Purchase of Investments | -1.56M | -2.62M | -2.18M | -2.21M | -6.44M | n/a | -14.87M | -2.22M | -3.77M | -3.81M |
Sales Maturities Of Investments | n/a | n/a | 217K | n/a | 4.42M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -28.45M | n/a | -2.03M | 1.6M | -3.07M | -44.5M | n/a | n/a |
Investing Cash Flow | -20.03M | -41.75M | -49.07M | -32.02M | -12.18M | -40.72M | -36.84M | -142.1M | -85.66M | -2.73B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | -161.87M | -88.21M | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.03M | -88.13M | -160.97M | -94.37M | 17.42M | -110.04M | 9.71M | -8.26M | -528K | 1.47B |
Financial Cash Flow | 9.03M | -88.13M | -160.97M | -94.37M | 17.42M | -110.04M | 9.71M | -8.26M | -528K | 1.47B |
Net Cash Flow | 153.01M | -41.19M | 222.32M | 237.97M | 250.03M | 63.11M | 511.77M | 256.23M | 710K | -1.27B |
Free Cash Flow | 143M | 47.2M | 379.28M | 336.65M | 239.04M | 176.59M | 518.58M | 337.1M | 75.48M | -22.06M |